TENET HEALTHCARE CORP (THC) Stock Analyst Earnings Estimates
NYSE:THC - New York Stock Exchange, Inc. - US88033G4073 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.485B 10.46% | 19.174B -1.60% | 20.548B 7.17% | 21.039B 2.39% | 21.555B 2.45% | 22.536B 4.55% | 24.05B 6.72% | 25.032B 4.08% | 26.125B 4.37% | 27.281B 4.42% | 28.463B 4.33% | 29.667B 4.23% | |
| EBITDA YoY % growth | 3.073B 45.30% | 3.128B 1.79% | 3.666B 17.20% | 4.004B 9.22% | 4.12B 2.90% | 4.378B 6.26% | 4.97B 13.52% | 5.245B 5.53% | 5.535B 5.53% | 5.84B 5.51% | 6.1B 4.45% | 6.351B 4.11% | |
| EBIT YoY % growth | 2.218B 76.31% | 2.287B 3.11% | 2.796B 22.26% | 3.162B 13.09% | 3.273B 3.51% | 3.434B 4.92% | 4.127B 20.18% | 4.402B 6.66% | 4.691B 6.57% | 4.996B 6.50% | 5.257B 5.22% | 5.508B 4.77% | |
| Operating Margin | 11.38% | 11.93% | 13.61% | 15.03% | 15.18% | 15.24% | 17.16% | 17.59% | 17.96% | 18.31% | 18.47% | 18.57% | |
| EPS YoY % growth | 7.58 -4.05% | 6.83 -9.89% | 6.98 2.20% | 11.24 60.98% | 11.52 2.53% | 13.08 13.51% | 15.01 14.77% | 16.22 8.08% | 17.78 9.59% | 18.76 5.51% | 19.30 2.91% | 21.19 9.79% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.96 10.40% | 3.14 -2.36% | 2.55 10.32% | 2.76 -5.97% | 3.19 7.93% | 3.51 11.62% | 2.91 14.21% | 3.11 13.02% | 3.63 13.77% |
| Revenue Q2Q % growth | 5.248B -2.44% | 5.35B -0.34% | 5.303B 3.92% | 5.356B 4.57% | 5.509B 4.97% | 5.559B 3.91% | 5.574B 5.11% | 5.587B 4.31% | 5.82B 5.65% |
| EBITDA Q2Q % growth | 1.031B -38.96% | 1.029B -0.58% | 984.61M -17.95% | 1.01B -27.34% | 1.089B 5.63% | 1.079B 4.86% | 1.054B 7.05% | 1.073B 6.24% | 1.159B 6.43% |
| EBIT Q2Q % growth | 822.7M 0.45% | 805.12M -2.65% | 765.22M -2.40% | 795.55M 3.99% | 869.09M 5.64% | 858.7M 6.65% | 816.01M 6.64% | 843.09M 5.98% | 935.35M 7.62% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.93 103.47% | 2.39 | 0.54 | 22.34% |
| Q2 2024 Q2Q % growth | 2.31 60.42% | 1.92 | 0.39 | 20.57% |
| Q1 2024 Q2Q % growth | 3.22 126.76% | 1.44 | 1.78 | 123.42% |
| Q4 2023 Q2Q % growth | 2.68 36.73% | 1.62 | 1.06 | 65.63% |
| Q3 2023 Q2Q % growth | 1.44 | 1.21 | 0.23 | 19.22% |
| Q2 2023 Q2Q % growth | 1.44 -4.00% | 1.26 | 0.18 | 14.18% |
| Q1 2023 Q2Q % growth | 1.42 -26.42% | 1.17 | 0.25 | 21.67% |
| Q4 2022 Q2Q % growth | 1.96 -27.41% | 1.24 | 0.72 | 58.14% |
| Q3 2022 Q2Q % growth | 1.44 -27.64% | 1.23 | 0.21 | 16.94% |
| Q2 2022 Q2Q % growth | 1.50 -5.66% | 0.80 | 0.70 | 87.33% |
| Q1 2022 Q2Q % growth | 1.93 48.46% | 1.05 | 0.88 | 83.67% |
| Q4 2021 Q2Q % growth | 2.70 -42.80% | 1.51 | 1.19 | 79.27% |
| Q3 2021 Q2Q % growth | 1.99 210.94% | 1.03 | 0.96 | 92.58% |
| Q2 2021 Q2Q % growth | 1.59 26.19% | 1.08 | 0.51 | 47.72% |
| Q1 2021 Q2Q % growth | 1.30 1.56% | 0.73 | 0.57 | 77.68% |
| Q4 2020 Q2Q % growth | 4.72 376.77% | 1.77 | 2.95 | 166.59% |
| Q3 2020 Q2Q % growth | 0.64 10.34% | 0.31 | 0.33 | 103.75% |
| Q2 2020 Q2Q % growth | 1.26 125.00% | -0.72 | 1.98 | 274.68% |
| Q1 2020 Q2Q % growth | 1.28 137.04% | 0.33 | 0.95 | 293.43% |
| Q4 2019 Q2Q % growth | 0.99 | 0.99 | 0.00 | -0.42% |
| Q3 2019 Q2Q % growth | 0.58 | 0.32 | 0.26 | 82.72% |
| Q2 2019 Q2Q % growth | 0.56 | 0.45 | 0.11 | 24.98% |
| Q1 2019 Q2Q % growth | 0.54 | 0.30 | 0.24 | 82.35% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 5.122B 1.11% | 5.103B | 19M | 0.37% |
| Q2 2024 Q2Q % growth | 5.103B 0.41% | 5.053B | 50M | 0.99% |
| Q1 2024 Q2Q % growth | 5.368B 6.91% | 5.204B | 164M | 3.15% |
| Q4 2023 Q2Q % growth | 5.379B 7.80% | 5.346B | 33M | 0.62% |
| Q3 2023 Q2Q % growth | 5.066B 5.52% | 5.074B | -8M | -0.16% |
| Q2 2023 Q2Q % growth | 5.082B 9.57% | 4.957B | 125M | 2.52% |
| Q1 2023 Q2Q % growth | 5.021B 5.82% | 4.892B | 129M | 2.64% |
| Q4 2022 Q2Q % growth | 4.99B 2.76% | 4.988B | 2M | 0.04% |
| Q3 2022 Q2Q % growth | 4.801B -1.90% | 4.862B | -61M | -1.25% |
| Q2 2022 Q2Q % growth | 4.638B -6.38% | 4.827B | -189M | -3.92% |
| Q1 2022 Q2Q % growth | 4.745B -0.75% | 4.752B | -7M | -0.15% |
| Q4 2021 Q2Q % growth | 4.856B -1.20% | 5.055B | -199M | -3.94% |
| Q3 2021 Q2Q % growth | 4.894B 7.40% | 4.855B | 39M | 0.80% |
| Q2 2021 Q2Q % growth | 4.954B 35.80% | 4.839B | 115M | 2.38% |
| Q1 2021 Q2Q % growth | 4.781B 5.77% | 4.814B | -33M | -0.69% |
| Q4 2020 Q2Q % growth | 4.915B 2.27% | 4.934B | -19M | -0.39% |
| Q3 2020 Q2Q % growth | 4.557B -0.24% | 4.447B | 110M | 2.47% |
| Q2 2020 Q2Q % growth | 3.648B -20.00% | 3.798B | -150M | -3.95% |
| Q1 2020 Q2Q % growth | 4.52B -0.55% | 4.674B | -154M | -3.29% |
| Q4 2019 Q2Q % growth | 4.806B | 4.805B | 1M | 0.02% |
| Q3 2019 Q2Q % growth | 4.568B | 4.503B | 65M | 1.44% |
| Q2 2019 Q2Q % growth | 4.56B | 4.524B | 36M | 0.80% |
| Q1 2019 Q2Q % growth | 4.545B | 4.558B | -13M | -0.29% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.13% | 31.76% | 0% | 1.7% |
| Revenue | 0.15% | 0.06% | 0% | 0.27% |